<code id='169C8758EE'></code><style id='169C8758EE'></style>
    • <acronym id='169C8758EE'></acronym>
      <center id='169C8758EE'><center id='169C8758EE'><tfoot id='169C8758EE'></tfoot></center><abbr id='169C8758EE'><dir id='169C8758EE'><tfoot id='169C8758EE'></tfoot><noframes id='169C8758EE'>

    • <optgroup id='169C8758EE'><strike id='169C8758EE'><sup id='169C8758EE'></sup></strike><code id='169C8758EE'></code></optgroup>
        1. <b id='169C8758EE'><label id='169C8758EE'><select id='169C8758EE'><dt id='169C8758EE'><span id='169C8758EE'></span></dt></select></label></b><u id='169C8758EE'></u>
          <i id='169C8758EE'><strike id='169C8758EE'><tt id='169C8758EE'><pre id='169C8758EE'></pre></tt></strike></i>

          Home / entertainment / hotspot

          hotspot


          hotspot

          author:hotspot    Page View:1453
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In